144 related articles for article (PubMed ID: 10863854)
1. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma].
Alvarez R; Bañares R; Echenagusía A; Carneros JA; Santos L; Simó G; Camúñez F
Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
3. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
5. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
6. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
Lu W; Li Y; He X; Chen Y
Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis.
Kim HC; Chung JW; Choi SH; Yoon JH; Lee HS; Jae HJ; Lee W; Park JH
J Vasc Interv Radiol; 2007 May; 18(5):611-9; quiz 620. PubMed ID: 17494842
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
10. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
11. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
12. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
Cioni G; Turrini F; Pedrazzini PG; Cristani A; Ventura E; Ferrari A; D'Alimonte P; Ariosi P; De Santis M
Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
[TBL] [Abstract][Full Text] [Related]
17. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
[TBL] [Abstract][Full Text] [Related]
18. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
20. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials.
Wang X; Li J; Peng Y; Dai Y; Xu W
Hepatogastroenterology; 2011; 58(107-108):869-74. PubMed ID: 21830407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]